Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
NYU Langone Health - Associate Professor, Department of Population Health
Education
PhD, Psychology, New School for Social ResearchMA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College
Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis BIO
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta-analysis, respondent driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease. Publications
Recent
Shelley D, Armstrong-Hough M, Nguyen T, Guevera Alvarez G, Kapur R, Shuter J, Goldsamt L, Tozan Y, Minh HV, Phan PT, Cleland CM, Nguyen N (2026).
Effectiveness of behavioural tobacco cessation interventions with and without pharmacotherapy among people living with HIV in Viet Nam: A three-arm pragmatic randomised controlled trial
Lancet Global Health, 14 (3), e407-e416. doi: 10.1016/S2214-109X(25)00451-6.
Effectiveness of behavioural tobacco cessation interventions with and without pharmacotherapy among people living with HIV in Viet Nam: A three-arm pragmatic randomised controlled trial
Lancet Global Health, 14 (3), e407-e416. doi: 10.1016/S2214-109X(25)00451-6.
Bunting AM, Griffin B, Rubens A, Lima D, Lam V, Bender M, Fawole A, McNeely J, Cleland CM (2026).
Refining a novel measure of polysubstance use: Applying the cognitive interview method with people who use drugs
Substance Use and Misuse [Epub 2026 Feb 20]. doi: 10.1080/10826084.2026.2632181.
Refining a novel measure of polysubstance use: Applying the cognitive interview method with people who use drugs
Substance Use and Misuse [Epub 2026 Feb 20]. doi: 10.1080/10826084.2026.2632181.
Bunting AM, Cleland CM, Barratt SM, Griffin B, Williams J, Oser CB, Lee JD, McNeely J (2026).
The polysubstance assessment tool: Reliability, acceptability and feasibility of a novel measure of polysubstance use
Addiction [Epub 2026 Feb 12]. doi: 10.1111/add.70349.
The polysubstance assessment tool: Reliability, acceptability and feasibility of a novel measure of polysubstance use
Addiction [Epub 2026 Feb 12]. doi: 10.1111/add.70349.
Doran KM, Welch AE, Kepler KL, Jeffers A, Chambless D, Cowan E, Wittman I, Regina A, Siu K, Bailey VS, Rostam-Abadi Y, Kennedy J, Kunins HV, Gwadz M, Shelley D, Cleland CM, McNeely J (2026).
Peer navigator intervention and opioid-related adverse events for emergency department patients: A randomized clinical trial
JAMA Network Open, 9 (2), e2555903. doi: 10.1001/jamanetworkopen.2025.55903. PMCID: PMC12881982.
Peer navigator intervention and opioid-related adverse events for emergency department patients: A randomized clinical trial
JAMA Network Open, 9 (2), e2555903. doi: 10.1001/jamanetworkopen.2025.55903. PMCID: PMC12881982.
Cluesman SR, Gwadz M, Cleland CM (2026).
PrEP intentions, heavy substance use, and gender affirmation among Black and Latine transgender and gender-expansive youth: A structural equation modeling analysis
AIDS and Behavior, 30 (2), 535-557. doi: 10.1007/s10461-025-04897-3.
PrEP intentions, heavy substance use, and gender affirmation among Black and Latine transgender and gender-expansive youth: A structural equation modeling analysis
AIDS and Behavior, 30 (2), 535-557. doi: 10.1007/s10461-025-04897-3.
Notable
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.
Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .
Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.
Dr. Cleland's Research Gate Profile
Selected Press